文献速递角膜与眼表疾病

非裔美国人中Fuchs角膜内皮营养不良患者的TCF4基因CTG18.1扩增

CTG18.1 Expansion in TCF4 Among African Americans With Fuchs' Corneal Dystrophy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

在一家三级医疗中心3年内评估59,365名自报黑人或白人白内障患者,黑人较白人患Fuchs角膜内皮营养不良的比值比为0.6992(95%CI 0.6210-0.7872)。纵向队列中60名黑人和549名白人患者,CTG18.1三核苷酸重复扩增(>40次)比例黑人35.0%对白人62.5%,差异显著(P=7.7×10-5)。多变量线性回归显示重复扩增而非种族与平均临床严重程度分级显著相关。

要点

  • 黑人白内障患者中Fuchs角膜内皮营养不良的比值比为0.6992(95%CI 0.6210-0.7872),低于白人。
  • 纵向队列中CTG18.1扩增比例黑人35.0%(21/60)对白人62.5%(343/549),差异显著(P=7.7×10-5)。
  • 多变量线性回归显示重复扩增而非种族与平均临床严重程度分级显著相关。

核心结论

  • 黑人Fuchs角膜内皮营养不良患者较白人更少出现CTG18.1等位基因扩增。
  • 数据有助于理解临床表现的人群差异,并强调临床研究中考虑患者人群多样性的必要性。

研究设计与样本

  • 在一家三级医疗中心对3年内所有自报黑人和白人、年龄大于40岁、诊断为白内障的患者评估Fuchs角膜内皮营养不良并发诊断。
  • 纵向队列中受影响患者提供血样提取基因组DNA,采用两步三核苷酸重复引物PCR法测定CTG18.1三核苷酸重复长度,扩增定义为>40次CTG重复。

主要发现

  • 59,365名自报黑人和白人成人中,黑人较白人患Fuchs角膜内皮营养不良的比值比为0.6992(95%CI 0.6210-0.7872)。
  • 纵向队列纳入60名黑人和549名白人Fuchs角膜内皮营养不良患者,CTG18.1扩增比例黑人35.0%(21/60)对白人62.5%(343/549),差异显著(P=7.7×10-5)。
  • 多变量线性回归模型中,重复扩增而非种族与平均临床严重程度分级显著相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Studies of Fuchs' dystrophy have largely focused on individuals of European origin. Characterization of disease among African Americans is required to ensure prognostic factors and therapeutic approaches are applicable across diverse patient populations. METHODS: We assessed all self-reported black and white patients aged older than 40 years at a tertiary care institution with a diagnosis of cataract over a 3-year period for concurrent diagnosis of Fuchs' dystrophy. Affected patients in a longitudinal cohort were invited to provide a blood sample from which we extracted genomic DNA. The CTG18.1 trinucleotide repeat length was determined using a two-step, triplet repeat primed PCR protocol. Expansion was defined as >40 CTG repeats. Demographic information, including race, was documented. RESULTS: Of 59,365 self-reported black and white adults who presented for cataract evaluation, the odds ratio of presenting with Fuchs' dystrophy among black compared to white patients was 0.6992 (95% confidence interval [CI], 0.6210-0.7872). A total of 60 black and 549 white patients with Fuchs' corneal dystrophy enrolled in the longitudinal study, of which 21 (35.0%) black and 343 (62.5%) white patients demonstrated trinucleotide repeat expansion, a significant difference (P = 7.7 × 10-5). In a multivariable linear regression model, repeat expansion but not race was significantly associated with mean clinical grading of severity. CONCLUSIONS: Black patients with Fuchs' dystrophy were less likely than white patients to demonstrate CTG18.1 allele expansion. The data contribute to our understanding of population differences in clinical presentation, and highlight the need for considering diversity of patient populations in clinical research.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Eghrari AO, Vahedi S, Afshari NA, et al. CTG18.1 Expansion in TCF4 Among African Americans With Fuchs' Corneal Dystrophy. Invest Ophthalmol Vis Sci. 2017. PMID: 29196769. doi:10.1167/iovs.17-21661

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。